The beat-and-raise confirms UNH's operational recovery is accelerating. With MCR improving, margins expanding, and guidance raised meaningfully, the stock should re-rate higher. Watch for continued membership trends in Medicare Advantage and Medicaid, and execution on the transparent PBM model. The raised cash flow guidance (~$24B) supports the buyback trajectory.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 16 $423.38entry
- T+1 · 4mo ago +0.64%α +1.63% · $426.09
- T+5 · 4mo ago +0.04%α +1.71% · $423.56
- T+20 · 3mo ago −5.74%α −9.36% · $399.06
- T+60 · 6w ago −10.41%α −14.12% · $379.30
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
UnitedHealth Group reported Q2 2026 GAAP EPS of $6.04 (vs consensus $4.87, +24.0% beat) and revenue of $112.0B (vs consensus $110.82B, +1.1% beat). The company raised full-year 2026 adjusted EPS guidance to $19.50-$20.00 from prior >$17.75, driven by strong medical cost management (MCR 86.7% vs 89.4% a year ago) and improved operating margins across both UnitedHealthcare and Optum. The beat-and-raise signals accelerating operational recovery from 2025 headwinds.
Key Financial Metrics
Key Facts
- Q2 2026 GAAP EPS $6.04 vs consensus $4.87 (beat by +24.0%)
- Q2 2026 revenue $112.0B vs consensus $110.82B (beat by +1.1%)
- Full-year 2026 adjusted EPS guidance raised to $19.50-$20.00 from >$17.75
- Medical cost ratio improved to 86.7% from 89.4% YoY, reflecting pricing discipline and cost management
- Operating cash flow $11.1B (1.9x net income), debt-to-capital ratio improved to 41.2%
- UnitedHealthcare operating margin expanded to 4.6% from 2.4% YoY
- Optum operating margin expanded to 6.2% from 4.6% YoY (160 bps)
- Share repurchases of $4.0B through mid-July; on track for at least $5.0B in 2026
Financial Impact
EPS beat of $1.17 (+24.0%) vs consensus; revenue beat of $1.18B (+1.1%); guidance raised by ~$1.75 at midpoint
Risk Factors
- Medicare Advantage membership declined 965K since year-end 2025; continued attrition could pressure future revenue
- Operating cost ratio increased to 12.7% from 12.3% YoY due to technology investments
- Optum Health revenue declined 5% YoY on 700K fewer value-based care patients
- DOJ legal actions concerning Medicare program participation remain an overhang
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000731766-26-000191 |
| Document: uhgearnings_q22026vpower.htm | 0000731766-26-000191 |
| Document: unh-20260716.htm | 0000731766-26-000191 |
| Document: 0000731766-26-000191-index-headers.html | 0000731766-26-000191 |
| Document: 0000731766-26-000191-index.html | 0000731766-26-000191 |
| Document: 0000731766-26-000191.txt | 0000731766-26-000191 |
| 8-K Data (Synthetic) | 0000731766-26-000191 |
Track record
63 reports on UNH
12 of 15 bullish or bearish reports moved the stock their way by T+1. Best: +23.07% at T+60 after the Apr 22, 2026 report. 12 of 15 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $407.00 Now $412.02 +1.23% settles Nov 17
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $405.12 to $402.94 Now $412.02 +1.70% ▼ −0.54% −1.86% vs SPY
- Oct 20, 202627d ago Institutional Cluster Mixed 4/10 Entry $417.00 to $424.98 Now $412.02 −1.19% ▲ +1.91% +3.09% vs SPY
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $377.76 to $395.62 Now $412.02 +9.07% ▲ +4.73% +5.81% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $371.90 to $378.58 Now $412.02 +10.79% ▲ +1.80% +1.12% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 30, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $365.20 to $371.90 Now $412.02 +12.82% ▲ +1.83% +1.10% vs SPY
- Sep 17, 20268w ago GOVT-CONTRACT Neutral 2/10 Entry $376.90 to $377.56 Now $412.02 +9.32% ▲ +0.18% −1.38% vs SPY
- Sep 11, 20269w ago Court Ruling Bullish 5/10 Entry $383.55 to $375.93 Now $412.02 +7.42% ▼ −1.99% −1.53% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers